Acute kidney injury and extracorporeal blood purification in sepsis

Management of Sepsis: The PIRO Approach

Volumn , Issue , 2009, Pages 97-116

  Moliner, Javier Maynar ^a   Riera, José Ángel Sánchez Izquierdo ^b   Gutiérrez, Manuel Herrera ^c   Rodero, Amaia Quintano ^a   Ramirez, Alberto Manzano ^a  

^a HOSPITAL TXAGORRITXU   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890239754     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-00479-7_8     Document Type: Chapter

References (95)

1. Hank WK, Bonventie JV (2004) Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 10:476-482
2. Kellum JA, Levin N, Bouman C, Lameire N (2002) Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 8:509-514
3. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G (1987) Risk factors and outcome of hospital-acquired acute renal failure. Am J Med 83:65-71
4. Levy EM, Viscoli CM, Horwitz RI (1996) The effect of acute renal failure on mortality: A cohort analysis. JAMA 75:1489-1494
5. Liaño F, Junco E, Pascual J, Madero R, Verde E (1998) The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int 66:S16-S24
6. Herrera ME, Seller G, Maynar J, Sánchez-Izquierdo JA, et al. (2006) Epidemiología del FRA en las UCI españolas: Estudio prospectivo multicéntrico FRAMI. Med Intensiva 30:260-267
7. Maynar J, Corral E, Gainza J, et al. (1997) Acute renal failure in critically ill patients: a descriptive, prospective multicenter study. Preliminary results [Abstract]. Intens Care Med 23:S142
8. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, et al., for the beginning and ending supportive therapy for the kidney (BEST Kidney) investigators (2005) Acute Renal Failure in Critically Ill Patients A Multinational, Multicenter Study. JAMA 294:813-818
9. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ (1996) Acute renal failure in intensive care units: Causes, outcome, and prognostic factors of hospital mortality - A prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 24:192-198
10. Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159-169
11. Hoste EA, Lameire NH, Vanholder RC, et al. (2003) Acute renal failure in patients with sepsis in a surgical ICU: Predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 14:1022-1030
12. Riedemann NC, Guo RF, Ward PA (2003) The enigma of sepsis. J Clin Invest 112:460-467
13. Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, et al. (2006) RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort análisis. Critical Care 10:R73
14. Ricci Z, Ronco C, D'amico G, et al. (2006) Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 21:690-696
15. Bellomo R, Ronco C, Kellum JA, ADQI workgroup (2004) Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care Med 8:204-212
16. Ostermann M, Chang R W S (2007) Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 35:1837-1843
17. Herrera ME, Seller G, Banderas E Moreno J, Lebrón M, Quesada J (2008) Diferencias en la clasificación de pacientes usando la escala RIFLE según el parámetro de estimación de GFR empleado [Abstract]. Med Intensiva 32:22
18. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, et al. (2004) Minimal changes of serum creatinine predict prognosis in patients alter cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:1597-1605
19. Chertow GM, Burdick E, Honour M, et al. (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365-3370
20. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury; Acute Kidney Injury Network. Critical Care 11:R31
21. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intens Care Med 29:530-538
22. Mehta R, Chertow GM (2003) Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 14:2178-2187
23. Liaño F, Gallego A, Pascual J, et al. (1993) Prognosis of ATN: an extended prospectively contrasted study. Nephron 63:21-31
24. Douma CE, Redekop WK, Van Den Meulen J H P, et al. (1997) Predicting mortality in ICU patients with ARF treated with dialysis. J Am Soc Nephrol 8:111-117
25. Trof RJ, Di Maggio F, Leemreis J, Groeneveld J (2006) Biomarkers of acute renal injury and renal failure. Shock 26:245-253
26. Han WK, Bailly V, Abichandani R, et al. (2002) Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:237-244
27. Cheyron D, Daubin C, Poggioli J, et al. (2003) Urinary measurement of Na-/H-exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis 42:497-506
28. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT (2006) Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105:485-491
29. Bagshaw SM, Langenberg C, Bellomo R (2006) Urinary biochemistry and microscopy in septic acute renal failure: A systematic review. Am J Kidney Dis 48:695-705
30. Villa P, Jiménez M, Soriano MC, et al. (2005) Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 9:R139-R143
31. Delanaye P, Lambermont B, Chapelle JP, et al. (2004) Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intens Care Med 30:980-983
32. Le Bricon T, Leblanc I, Benlakehal M, et al. (2005) Evaluation of renal function in intensive care: plasma cyctatin C vs. creatinine and derived glomerular filtration rate stimates. Clin Chem Lab Med 43:953-957
33. Knight EL, Verhave JC, Spielgelman D, et al. (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:1416-1421
34. Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 40:221-226
35. Herrera ME, Seller G, Banderas E, Muñoz J, Lebrón M, Fernández F (2007) Replacement of 24-h creatinine clearance by 2-h creatinine clearance in intensive care unit patients: a singlecenter study. Intens Care Med 33:1900-1906
36. Seller G, Herrera ME, Banderas E Moreno J, Lebrón M, Muñoz J (2007) Utilidad de las fórmulas de Cockroft-Gault y Jeliffe para calcular el aclaramiento de creatinina en UCI [Abstract]. Med Intensiva 31:42
37. Maynar J y Sánchez-Izquierdo JA (2001) Editores de la Monografía. Fallo Renal Agudo y Técnicas de Reemplazo Renal. Barcelona. EDIKAMED. ISBN 84-7877-290-1
38. Uchino S, Doig GS, Bellomo R, et al. (2004) Diuretics and mortality in acute renal failure. Crit Care Med 32:1669-1677
39. Rivers M, Nguyen B, Havstad S, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
40. Vincent J-L Sakr Y, Sprun CL (2006) Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 34:344-353
41. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564-2575
42. Dalfino L, Tullo L, Donadio I, et al. (2008) Intra-abdominal hipertensión and acute renal failure in critically ill patients. Intens Care Med 34:707-713
43. Malbrain ML, Cheatham ML, Kirkpatrick A, et al. (2006) Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. I. Definitions. Intens Care Med 32:1722-1732
44. Cheatham ML, Malbrain M, Kirkpatrick A, et al. (2007) Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. II. Recommendations. Intens Care Med 33:951-962
45. Garella S, Matarese RA (1984) Renal effects of prosta-glandins and clinical adverse effects of nonsteroidal antiinflammatory agents. Medicine 63:165-181
46. Barza M, Ioannidis JP, Cappelleri JC, Lau J (1996) Single or multiple daily doses of aminoglycosides: a meta-análisis. BMJ 312:338-344
47. Barrett BJ, Carlisle EJ (1993) Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 188:171-178
48. Solomon R, Deray G (2006) How to prevent contrast induced nephropathy and manage risk patients: practical recommendations. Proceedings of the contrast-induced nephropathy consensus panel. Kidney Int 69(Suppl. 100):S51-S53
49. Venkataraman R, Kellum JA (2007) Prevention of acute renal failure. Chest 131:300-308
50. Holmes CL, Walley KR (2003) Low-dose dopamine in the ICU. Chest 123:1266-1275
51. Uchino S, Bellomo R, Morimatsu H, et al. (2007) Continuous renal replacement therapy: A worldwide practice survey. The beginning and ending supportive therapy for the kidney (BEST Kidney) investigators. Intens Care Med 33:1563-1570
52. Van Bommel E F H, Ponssen HH (1997) Intermittent versus continuous treatment for acute renal failure: Where do we stand? Am J Kidney Dis 30:S72-S79
53. Mehta RL (1997) Continuous renal replacement therapies in the acute renal failure setting: Current concepts. Adv Renal Replacement Ther 4:S81-S92
54. Bellomo R, Ronco C (1999) Continuous renal replacement therapy in the intensive care unit. Intens Care Med 25:781-789
55. Silvester W (1998) Outcome studies of continuous renal replacement therapy in the intensive care. Kidney Int 53:S138-S141
56. Mehta R, McDonald B, Gabbai F, et al. (1996) Continuous versus intermittent dialysis for acute renal failure in the ICU: results from a randomized multicenter trial. J Am Soc Nephrol 5:1457-1462
57. Kellum JA, Angus DC, Johnson JP, et al. (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intens Care Med 28:29-37
58. Bell M, Swing, Granath F, Schön S, Ekbom A, Roland Martling C (2007) Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis alter acute renal failure. Intens Care Med 33:773-780
59. Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R (2008) Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis. Crit Care Med 36:610-617
60. Chang JW, Yang WS, Seo JW, Lee JS, Lee SK, Park SK (2004) Continuous venovenous hemofiltration versus hemodiálisis as renal replacement therapy in patients with acute renal failure in the intensive care unit. Scand J Urol Nephrol 38:417-421
61. Vinsonneau Ch, Camus Ch, Combes A, et al. (Hemodiafe Study Group) (2006) Continuous venovenous haemofiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction síndrome: a randomised trial. Lancet 368:379-385
62. Uehlinger DE, Jakob SM, Ferrari P, et al. (2005) Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 20:1630-1637
63. Augustine JJ, Sandy D, Seifert TH, Paganini EP (2004) A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 44:1000-1007
64. Vanholder R, Van Biesen W I M, Lameire N (2001) What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol 12:S40-S43
65. Ronco C, Bellomo R, Homel P, et al. (2000) Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26-30
66. Schiffl H, Lang S, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Eng J Med 346:305-310
67. The VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008 359:7-20
68. Several authors. (2008) Renal support in critically ill patients with acute kidney injury. N Engl J Med 359(18):1959-1962
69. Honoré PM, Jamez J, Wauthier M, et al. (2000) Prospective evaluation of short-term, highvolume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581-3587
70. Jiang HL, Xue WJ, Li DQ, Yin AP, Xin X, Li CM, Gao JL (2005) Influence of continuous venovenous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 11:4815-4821
71. Cole L, Bellomo R, Journois D, et al. (2001) High-volume haemofiltration in human septic shock. Intens Care Med 27:978-986
72. Luyckx VA and Bonventre JV (2004) Dose of dialysis in acute renal failure. Sem Dialysis 17:30-36
73. Maynar-Moliner J, Sánchez-Izquierdo-Riera JA, Herrera-Gutierrez M (2008) Renal support in critically ill patients with acute kidney injury. N Engl J Med 359:1960
74. Herrera Gutierrez M, Seller Pérez G, Lebrón Gallardo M, Muñoz Bono J, Banderas Bravo E, Cordón López A (2006) Early hemodynamic improvement is a prognostic marker in patients treated with continuous CVVHDF for acute renal failure. ASAIO J 52:670-676
75. Ricci Z, Ronco C, Bachetoni A, D'amico G, Rossi St (2006) Solute removal during continuous renal replacement therapy in critically ill patients: convection versus difusion. Crit Care 10:R67
76. Sander A, Armbruster W, Sander B, et al. (1995) The influence of continuous hemofiltration on cytokine elimination and the cardiovascular stability in the early phase of sepsis. Contrib Nephrol 116:99-103
77. Sanchez-Izquierdo Riera JA, Alted Lopez E, Lozano Quintana MJ, et al. (1997) Influence of continuous hemofiltration on the hemodynamics of trauma patients. Surgery 122:902-908
78. Honore PM, Joannes-Boyau O (2004) High volumen hemofiltration (HVHF) in sepsis: A comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Org 27:1077-1082
79. Oudemans-Van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF (1999) Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intens Care Med 25:814-821
80. Joannes-Boyau O, Rapaport St, Bazin R, Fleureau C, Janvier G (2004) Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50:102-109
81. Ratanarat R, Brendolan A, Piccinni P, et al. (2005) Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9:R294-R302
82. Piccinni P, Dan M, Barbacini St, et al. (2006) Early isovolemic haemofiltration in oliguric patients with septic shock. Intens Care Med 32:80-86
83. Hoffman JN, Hartl WH, Deppisch, et al. (1995) Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 48:1563-1570
84. Braun N, Rosenfeld S, Giolai M, et al. (1995) Effects of continuous hemodiafiltration on IL-6, TNF-alfa, C3a, and TCC in patients with SIRS/septic shock using two different membranes. Contrib Nephrol 116:89-98
85. Ronco C, Tetta C, Lupi A, et al. (1995) Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 23:99-107
86. Heering P, Morgera S, Schmitz FJ, et al. (1997) Cytokine removal and cardiovascular hemodynamics in septic patients with continuous veno-venous hemofiltration. Intens Care Med 23:288-296
87. Ronco C, Tetta C, Mariano F, et al. (2003) Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 27:792-801
88. Yekebas EF, Eisenberger C, Ohnesorge H, Saalmuller A, Elsner H, Engelhart M, et al. (2001) Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 29:1423-1430
89. Sanchez-Izquierdo Riera JA, Perez Vela JL, Lozano Quintana MJ, et al. (1997) Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis 30:483-488
90. Haase M, Bellomo R, Baldwin I, et al. (2007) Hemodialysis membrane with a high-molecularweight cutoff and cytokine levels in sepsis complicated by acute renal failure: A Phase 1 randomized trial. Am J Kidney Dis 50:296-304
91. Fortin MC, Amyot SL, Geadah D, Leblanc M (1999) Serum concentrations and clearances of folic acid and pyridoxal-5'Œ-phosphate during venovenous continuous renal replacement therapy. Crit Care Med 25:594-598
92. Story DA, Ronco C, Bellomo R (1999) Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration. Crit Care Med 27:220-223
93. Berger MM, Shenkin A, Revelly JP, et al. (2004) Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 80:410-416
94. Maynar J (2007) Extracoporeal clearance and extracorporeal clearance fraction: pharmacokinetic bases and drug dosing in continuous extracorporeal treatments. Nefrologia 27(3):247-255
95. Moran SM, Myers BD (1985) Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 27:928-927